Infusions and Special Medicines Board Expert Panel Working Group – Call for applications

At the national Quality Assurance and Technical Services symposium on the 9th of November we announced the launch of an Expert Panel to provide the governance and assurance for the product standardisation agenda.

This group will consist of professionals from a wide range of backgrounds, and we’d like to encourage as many people as possible to apply. It will initially meet to agree terms of reference and establish a work pattern. Members will then review and comment on the specifications, prompting a review of the documents before they are published for a public consultation. Once the consultation ends and any final alterations have been made the members will review once more before the official publication of the specifications.

This initial phase is focusing on chemotherapy agents and we will be looking for clinical specialists in that area. These specialists will rotate in and out of the group as we expand the project to cover other classes of medicines.

Once all existing products have been completed the group will only need to meet and provide this function on an ad-hoc basis as new medicines are marketed and dose banding tables established.

Details of the roles and the panel can be found here:FutureNHS Collaboration Platform – FutureNHS Collaboration Platform  and in the document available at this link https://www.bopa.org.uk/resources/expression-of-interest-slwg-infusions-and-special-medicines-expert-panel-standardisation/

Please circulate to your Trust teams, the deadline for applications is 23:59 25th Nov 2022 and should be done via this Form

Thanks, in advance,

Matt Greening

Senior Pharmacy Professional Advisor – Infusions and Special Medicines Programme

Latest News

By Suriya Marshall on 14th March 2026

Parliamentary Intervention Sparks National Campaign to Protect NHS Staff from Hazardous Medicinal Products (HMPs)

First UK Campaign to Protect Healthcare Workers from Exposure to Hazardous Medicinal Products (HMPs) launches in Westminster London, 10 March 2026: Today, the Safer Healthcare and Biosafety Network (SHBN) launches…

Read article
By Suriya Marshall on 14th March 2026

Clinical Pharmacy Congress. 8th-9th May 2026

Dear BOPA member, We are excited to announce that we have partnered with Clinical Pharmacy Congress 2026. Clinical Pharmacy Congress is the UK’s leading event for clinical pharmacy professionals working across…

Read article
By BOPA Executive Committee on 13th March 2026

First UK Campaign to Protect Healthcare Workers from Exposure to Hazardous Medicinal Products (HMPs) launches in Westminster

London, 10 March 2026: The Safer Healthcare and Biosafety Network (SHBN) launches a new campaign titled “Protecting Healthcare Workers: Safer Handling of Hazardous Medicinal Products” to raise awareness of the dangers…

Read article
By BOPA on 13th March 2026

Invitation to Participate: SWEET-PLUS Study

You are invited to take part in a research study called SWEET-PLUS (NIHR Research for Patient Benefit: 207952), run by Newcastle and Oxford Brookes Universities. SWEET-PLUS aims to understand experiences…

Read article